Argenica Therapeutics Limited (AGN.AX)
AUD 0.71
(-2.76%)
AUD 0.71
(-2.76%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 2.42 Million AUD | 29.46% |
| 2023 | 1.87 Million AUD | 154.71% |
| 2022 | 735.9 Thousand AUD | 72.86% |
| 2021 | 425.72 Thousand AUD | 18.5% |
| 2020 | 359.26 Thousand AUD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 2.42 Million AUD | 19.77% |
| 2024 Q4 | 2.42 Million AUD | 0.0% |
| 2024 Q1 | 2.02 Million AUD | 175.32% |
| 2024 FY | 2.42 Million AUD | 29.46% |
| 2024 Q2 | 2.02 Million AUD | 0.0% |
| 2023 Q3 | 1.87 Million AUD | 41.26% |
| 2023 FY | 1.87 Million AUD | 154.71% |
| 2023 Q2 | 1.32 Million AUD | 0.0% |
| 2023 Q1 | 1.32 Million AUD | 80.31% |
| 2023 Q4 | 735.9 Thousand AUD | -60.74% |
| 2022 Q4 | 735.9 Thousand AUD | 0.0% |
| 2022 Q1 | 58.45 Thousand AUD | -86.27% |
| 2022 Q3 | 735.9 Thousand AUD | 1158.95% |
| 2022 FY | 735.9 Thousand AUD | 72.86% |
| 2022 Q2 | 58.45 Thousand AUD | 0.0% |
| 2021 Q3 | 425.72 Thousand AUD | 628.72% |
| 2021 FY | 425.72 Thousand AUD | 18.5% |
| 2021 Q4 | 425.72 Thousand AUD | 0.0% |
| 2021 Q2 | 58.42 Thousand AUD | 0.0% |
| 2021 Q1 | 58.42 Thousand AUD | -83.74% |
| 2020 Q4 | 359.26 Thousand AUD | 0.0% |
| 2020 FY | 359.26 Thousand AUD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AdAlta Limited | 3.54 Million AUD | 31.498% |
| Acrux Limited | 5.68 Million AUD | 57.329% |
| Actinogen Medical Limited | 1.61 Million AUD | -50.227% |
| AnteoTech Limited | 4.07 Million AUD | 40.452% |
| Arovella Therapeutics Limited | 2.05 Million AUD | -17.995% |
| Anatara Lifesciences Ltd | 306.84 Thousand AUD | -690.852% |
| Alterity Therapeutics Limited | 5.42 Million AUD | 55.273% |
| Amplia Therapeutics Limited | 3.42 Million AUD | 29.184% |
| Avecho Biotechnology Limited | 941.54 Thousand AUD | -157.739% |
| Bio-Gene Technology Limited | 368.44 Thousand AUD | -558.637% |
| Biome Australia Limited | 5.37 Million AUD | 54.837% |
| Biotron Limited | 737.5 Thousand AUD | -229.043% |
| Botanix Pharmaceuticals Limited | 3.73 Million AUD | 34.977% |
| BTC Health Limited | 203.94 Thousand AUD | -1089.872% |
| Chimeric Therapeutics Limited | 12.8 Million AUD | 81.046% |
| CSL Limited | 27.88 Billion AUD | 99.991% |
| Clarity Pharmaceuticals Ltd | 8.33 Million AUD | 70.874% |
| Clinuvel Pharmaceuticals Limited | 28.11 Million AUD | 91.368% |
| Cynata Therapeutics Limited | 1.17 Million AUD | -107.225% |
| Dimerix Limited | 13.89 Million AUD | 82.533% |
| EZZ Life Science Holdings Limited | 4.22 Million AUD | 42.619% |
| Hexima Limited | 248.67 Thousand AUD | -875.88% |
| Island Pharmaceuticals Limited | 1.04 Million AUD | -132.083% |
| Immuron Limited | 2.84 Million AUD | 14.568% |
| Immutep Limited | 10.97 Million AUD | 77.898% |
| Imugene Limited | 33.14 Million AUD | 92.678% |
| Invex Therapeutics Ltd | 431.63 Thousand AUD | -462.222% |
| Memphasys Limited | 5.59 Million AUD | 56.607% |
| Nanollose Limited | 465.64 Thousand AUD | -421.155% |
| Neuren Pharmaceuticals Limited | 42.76 Million AUD | 94.325% |
| Noxopharm Limited | 1.28 Million AUD | -88.32% |
| NeuroScientific Biopharmaceuticals Limited | 85.68 Thousand AUD | -2732.207% |
| Nyrada Inc. | 855.63 Thousand AUD | -183.617% |
| Orthocell Limited | 22.08 Million AUD | 89.011% |
| PharmAust Limited | 896.6 Thousand AUD | -170.656% |
| Patrys Limited | 691.36 Thousand AUD | -251.004% |
| Paradigm Biopharmaceuticals Limited | 3.58 Million AUD | 32.297% |
| Proteomics International Laboratories Limited | 1.62 Million AUD | -49.252% |
| Prescient Therapeutics Limited | 2.32 Million AUD | -4.35% |
| PYC Therapeutics Limited | 10.18 Million AUD | 76.171% |
| Race Oncology Limited | 1.91 Million AUD | -26.627% |
| Radiopharm Theranostics Limited | 44.68 Million AUD | 94.569% |
| Recce Pharmaceuticals Ltd | 15.89 Million AUD | 84.731% |
| Starpharma Holdings Limited | 8.69 Million AUD | 72.1% |
| Telix Pharmaceuticals Limited | 249.39 Million AUD | 99.027% |
| Tissue Repair Ltd | 1.35 Million AUD | -79.637% |
| Zelira Therapeutics Limited | 9.35 Million AUD | 74.064% |